Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention

Completed · Not applicable

Conditions studied: Gastroesophageal Reflux Disease, Diabetic Gastroparesis

In brief

The investigators hypothesized that: 1\) an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.

Key facts

Study ID

NCT01126034

Run by

University of Pennsylvania

People needed

85

Starts

2007-03-01

Expected to finish

2008-04-01

Last updated by the study team

2015-12-04

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Physicians at University of Pennsylvania Health System who ordered an active metoclopramide prescription with a questionable indication.

You may not qualify if…

• Physicians-in-training (e.g., residents, fellows)
• Physicians how were investigators on this study
• Physicians serving on the the University of Pennsylvania Drug Use and Effects Committee or Information Technology Oversight Board

Where it is running

• University of Pennsylvania Center for Clinical Epidemiology and Biostatistics — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.